LivaNova Plc - Company Profile
Powered by 
All the data and insights you need on LivaNova Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date LivaNova Plc Strategy Report
- Understand LivaNova Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Business Description
LivaNova PLC (LivaNova) is engaged in the designing, development, manufacturing and distribution of therapeutic solutions in the areas of cardiac surgery and neuromodulation. The company offers its solutions to patients, healthcare professionals and healthcare systems.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
LivaNova’s R&D activities focuses on product design and development efforts, clinical study programs and regulatory activities, which are essential to its strategic portfolio initiatives, including DTD and heart failure. The company’s pipeline products are developed focused on therapy areas related to advanced circulatory support, cardiopulmonary, difficult-to-treat depression, drug-resistant epilepsy, heart failure, and obstructive sleep apnea. In FY2022, the company spent US$155.8 million on its R&D activities, amounting to 15.2% of the company’s annual revenue. As of December 31, 2022, the company held over 840 issued patents worldwide, with approximately 285 patent applications pending for approval that cover various aspects of its technology. The company has research facilities located in Brazil, Germany, Italy, Australia and the US.
Business Segments
Overview
Offers temporary life support product kits that can include a combination of pumps, oxygenators, and cannulae.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Develops, produces and sells cardiovascular surgery products such as oxygenators, heart-lung machines, autotransfusion systems, among others. - Key cardiopulmonary products include heart-lung machines, heater coolers, oxygenerators, perfusion tubing systems, perfusion charting system, autotransfusion systems, crannulae and other cardiac surgery equipment.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Designs, develops and markets neuromodulation therapy for the treatment of treatment resistant depression and drug-resistant epilepsy. - Key offering includes VNS therapy system that comprises an implantable pulse generator, a lead connecting the generator with the vagus nerve, surgical equipment that assists in the implant procedure, equipment for setting the pulse generator stimulation parameters for the patient, and magnets to suspend or induce stimulation manually.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes corporate shared service expenses for legal, finance, human resources and information technology.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer